The Effects of Unfiltered (Turkish) Coffee Consumption on Cardiovascular Risk Parameters
Launched by EASTERN MEDITERRANEAN UNIVERSITY · Apr 4, 2018
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
Background: Considerable controversy exists regarding the link between coffee consumption and cardiovascular disease (CVD) risk. It has been shown that different coffee preparation and brewing methods influence the concentration of compounds present in the final coffee brew. Unlike coffee traditionally consumed in the western world, Turkish coffee is not drip filtered, but rather its method of preparation involves slowly boiling water that is mixed with thinly ground coffee beans. This style of preparation results in a greater amount of biologically active components (caffeine and diterpene...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Regular Turkish coffee consumer ≥ 1 cups/day
- • Body mass index (BMI) 18.5-24.9 kg/m2 )
- • Non-smoker or former smoker (more than a year)
- • Willingness to abstain from coffee drinking
- • Willingness to consume ≥ 3 cups/day of Turkish coffee
- Exclusion Criteria:
- • Acute or chronic diseases
- • Severe illness with in-patient treatment during last 3 months
- • Use of regular medication or any supplements
- • Weight reduction ˃2 kg/week during the last month
- • Pregnancy or breastfeeding
- • Regular strong physical activity with ≥1h/day
- • High alcohol intake a weekly intake of ˃7 units for women and ˃14units for men
- • Excess consumption of total fat ˃35% of daily calories
- • Consumption of saturated fatty acid ˃10% of daily calories
- • Cholesterol intake ˃300mg/day
About Eastern Mediterranean University
Eastern Mediterranean University (EMU) is a leading institution dedicated to advancing research and education in the fields of health sciences and medicine. Renowned for its commitment to innovation and academic excellence, EMU engages in clinical trials that aim to enhance healthcare outcomes and contribute to the understanding of various medical conditions. With a collaborative approach, the university works alongside local and international partners to facilitate groundbreaking research initiatives, ensuring adherence to high ethical standards and regulatory compliance. EMU's focus on multidisciplinary research fosters an environment that encourages the translation of scientific discoveries into practical applications, ultimately benefiting patients and communities in the Eastern Mediterranean region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Famagusta, , Cyprus
Patients applied
Trial Officials
Tanju Besler, Prof.
Study Chair
Eastern Mediterranean University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials